16/12/2008 Merck Serono: European Commission Approves Cetuximab® for First-Line Use in Head and Neck Cancer

11/12/2008 Dipeptide blocks the formation of toxic amyloid β-peptide aggregates in mice

11/12/2008 COARTEM IS SAFE AND EFFECTIVE

11/12/2008 New England Journal of Medicine: Two new studies show malaria vaccine candidate advancing in Africa

10/12/2008 Accordo Pfizer Inc. e sigma-tau Industrie Farmaceutiche Riunite SpA

10/12/2008 DHA + PQP: A WINNER COMBINATION FOR NEW TREATMENT OF MALARIA

9/12/2008 A NEW PILL FOR TRANSIENT INSOMNIA AFTER SLEEP-TIME SHIFT: JET LAG

5/12/2008 LUMIGAN: A DRUG COULD HELP GROW EYELASHES

4/12/2008 FATE AND EFFECTS OF TAMIFLU IN THE ENVIRONMENT

1/12/2008 Biocitech

1/12/2008 95% OF THE BODY'S SUPPLY OF SEROTONIN IS PRODUCED IN THE GUT

18/11/2008 FDA Approves Banzel (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder

10/11/2008 PURPLE TOMATOES AS POTENTIAL ANTICANCER

9/11/2008 FDA Approves Rapaflo® (Silodosin) for BPH

3/11/2008 Cytheris Initiates Clinical Trial of Interleukin-7 (IL-7) as an Immunotherapy in HCV Patients

28/10/2008 EFSA calls for more scientists

24/10/2008 Pharmaceutical Research in Italy continuing to experience difficulties

24/10/2008 JASCO’s New European Headquarter’s Grand Opening Concludes its 50th Anniversary Celebration in 2008

22/10/2008 Newly developed Geniom RT Analyzer form febit

17/10/2008 A Phase I clinical trial of ImmuFact IMP321 in pancreatic cancer will be carried out at Washington University in Saint Louis

15/10/2008 Europe's largest and most influential antibody event.

15/10/2008 New Safinamide patent granted by European Patent Office (EPO)

13/10/2008 SILODOSIN FOR SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA

12/10/2008 Alzheimer’s Disease

12/10/2008 DIABETES

9/10/2008 Awarded the Nobel Prize in Chemistry for 2008

8/10/2008 Nobel Prize in Physiology or Medicine, 2008

26/9/2008 REDUCTION OF OSTEOPOROSIS BY AN INVESTIGATIONAL MONOCLONAL ANTIBODY: DENOSUMAB

26/9/2008 Scandal in China: milk contaminated with melamina

26/9/2008 Nice Approves Pradaxa(R) - 1st New Oral Anticoagulant In UK For Over 50 Years

8/9/2008 FOCUS AND PERSPECTIVE ON THE ITALIAN BIOTECH PIPELINE.

31/8/2008 Class Of Diabetes Drugs Carries Significant Cardiovascular Risks

31/8/2008 Black raspberries slow cancer by altering hundreds of genes

26/7/2008 The new oral formulation of TNP-470 called LODAMINE offers potential non toxic cancer therapy or metastasis prevention.

15/7/2008 Honokiol, a natural compound from magnolia cones, blocks a pathway for cancer growth

9/7/2008 THE FIRST LUNG CANCER VACCINE TO BE APPROVED BY CUBAN AUTHORITIES

3/7/2008 Start of Phase II Clinical Study for Italian AIDS Vaccine

2/7/2008 HTI-286, A NEW POTENT TUBULIN INHIBITOR ACTIVE IN THE PROSTATE CANCER

27/6/2008 ARENEGYR: A new agent for the treatment of cancer

23/6/2008 ORAL AGENT SHOWS PROMISE AGAINST MULTIPLE SCLEROSIS

20/6/2008 Zoledronic Acid Significantly Reduced Relapse in Early Breast Cancer

20/6/2008 ASA404: A SMALL-MOLECULE TUMOR-VASCULAR DISRUPTING AGENT

18/6/2008 A “SERENDIPITOUS” APPROACH UNCOVERED A NEUROGENIC SMALL MOLECULE

10/6/2008 BRISTOL-MYERS SQUIBB AND ASTRA ZENECA DEMONSTRED SIGNIFICANT REDUCTION IN KEY MEASURES OF GLUCOSE CONTROL IN TREATMENT WITH ONGLYZA(TM) OF NAÏVE PEOPLE WITH TYPE 2 DIABETS.

4/6/2008 Synthetic molecules developed by Hebrew University researchers hold promise for new family of anti-cancer drugs

27/5/2008 TARGETED CANCER TERAPY: FROM TRIAL TO CLINICAL

19/5/2008 First EU licence granted for pre- pandemic bird flu vaccine

19/5/2008 NEW CANCER VACCINES IN DEVELOPMENT

19/5/2008 Prana Announces Completion of Phase IIa Trial of PBT2 in Alzheimer's Disease Patients

16/5/2008 DEBIOPHARM SIGNS LICENSE AGREEMENT FOR MARKETING OF SALVACYL®/MOAPAR 3-MONTH FOR SEXUAL DEVIATIONS

4/5/2008 INNOCENTIVE ANNOUNCED THE TOP SOLVERS 2007

3/5/2008 The U.S. FDA ACCEPTS ORITAVANCIN NDA (New Drug Application)

3/5/2008 AN EXTRAORDINARY STORY FROM DAILYMAIL

30/4/2008 ALBERT HOFMANN, FATHER OF LSD, DEAD AT 102

29/4/2008 FDA Approves Cimzia® to Treat Crohn's Disease

24/4/2008 CETIRIZINE HYDROCHLORIDE ORAL SOLUTION

10/4/2008 Winners for 2008 EFMC Awards announced

8/4/2008 NEW VACCINE TO PREVENT GASTROENTERITIS CAUSED BY ROTAVIRUS

6/4/2008 NEW DRUG APPLICATION FOR TREANDA(R) BY CEPHALON

28/3/2008 POSITIVE RESULTS OF AN2728 IN PSORIASIS PATIENTS

14/3/2008 FIRST THERAPY APPROVED FOR TREATMENT OF CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS) A RARE, HEREDITARY, INFLAMMATORY DISEASE

13/3/2008 EMEA: STRONG PERFORMANCE IN 2007

13/3/2008 MULTIVITAMINS DO NOT REDUCE RISK FOR LUNG CANCER, AND VITAMIN E MAY RAISE IT

7/3/2008 Direct Thrombin Inhibitors: Alternatives to Heparin

7/3/2008 THE FDA APPROVED PRISTIQ FOR ANTIDEPRESSANT USE

7/3/2008 Cholesterol lowering mechanism of soybean protein hydrolysate identified

7/3/2008 U.S. REGULATORS IDENTIFIED CONTAMINANT IN BAXTER’S HEPARIN

11/2/2008 XELODA (CAPECITABINE) FOR TREATING METASTATIC COLORECTAL CANCER

11/2/2008 FROM INDUSTRY TO ACADEMIA

10/2/2008 INTELENCE™, A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, AGAINST HIV-1 INFECTION

7/2/2008 APPROUVED IN EUROPE THE NOVEL NOVARTIS’ ANTIDIABETES

1/2/2008 NEW RESEARCH: ALZHEIMERS PATIENTS IMPROVE DRAMATICALLY WITH ENBREL

31/1/2008 PHASE I STUDY OF AFP-464 IN PATIENTS WITH SOLID TUMORS

31/1/2008 NEW FDA ORPHAN DRUG FOR ORAL FLUDARABINE AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA

24/1/2008 ELLAGITANNIN-RICH POMEGRANATE EXTRACT CAN INHIBIT ANGIOGENESIS IN PROSTATE CANCER IN VITRO AND IN VIVO

23/1/2008 “THE GOLDEN PILL 2007” TO AN ORPHAN DRUG

21/1/2008 DR. JUDAH FOLKMAN, M.D., U.S. CANCER PIONEER, DIES (1933-2008)

21/1/2008 HIGHER INTAKE OF CAROTENOIDS AND VITAMIN E COULD REDUCE THE RISK OF DEVELOPING CATARACT

11/1/2008 ONLY 19 NEW DRUGS APPROVED BY FDA IN 2007

10/1/2008 SUPER RED WINE MIGHT BOOST LIFESPAN

8/1/2008 THE NEW ANTI-FUNGAL DRUG ANIDULAFUNGIN NOW IN EU-COUNTRIES

4/1/2008 FAVORABLES RESULTS FROM FIRST CLINICAL TRIAL OF FV-100, AN ORAL DRUG FOR THE TREATMENT OF SHINGLES.

4/1/2008 TELBIVUDINE FOUND BETTER AT SUPPRESSING HEPATITIS B VIRUS.

4/1/2008 HYDROXYUREA CHEMOTHERAPY AGAINST MENINGIOMAS

3/1/2008 CORRELATION BETWEEN OF A NOVEL SMALL HEAT SHOCK PROTEIN (HSP16.2) AND MALIGNANCY IN BRAIN TUMORS

3/1/2008 Phase III Clinical Trial Program for ALTROPANE®

3/1/2008 SIGNAL TRANSDUCTION INHIBITORS IN CANCER THERAPY

19/12/2007 FDA APPROVED KUVAN™ AGAINST HIGH LEVEL OF BLOOD PHENYLALANINE

11/12/2007 NEW COMPOUNDS FOR PAIN TREATMENT

10/12/2007 HEPARANASE EXPRESSION CORRELATES WITH THE PROGRESSION OF TONGUE CANCER AND WITH TUMOR SIZE

5/12/2007 SBIO INITIATES CLINICAL TRIAL OF NOVEL ANTI-CANCER DRUG

1/12/2007 COSMO'S RIFAMYCIN SV MMX™ MEETS CLINICAL ENDPOINTS IN PHASE II TRIAL FOR INFECTIOUS DIARRHOEA

26/11/2007 MONEY FOR BIOMEDICAL RESEARCH

24/11/2007 NEW ORPHAN DRUGS: AVI-4658, SQ109, ATIR

21/11/2007 Overcoming adversity, one drug at a time

20/11/2007 TREATMENT OF SCHIZOPHRENIA WITH SEROQUEL XR(TM) ADMINISTERED ONCE DAILY

13/11/2007 GALENO 2007: THE WINNER IS TIGECYCLINE

11/11/2007 TOPOTECAN HYDROCHLORIDE (HYCAMTIN®) FOR ORAL USE.

11/11/2007 APPROVED BY THE US FDA TASIGNA® (NILOTINIB) FOR THE TREATMENT OF CML

7/11/2007 COMBIGAN, A WINNER COMBINATION FOR REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION

28/10/2007 FDA APPROVES IXEMPRA (IXABEPILONE), FOR ADVANCED BREAST CANCER PATIENTS

28/10/2007 ISENTRESS® (RALTEGRAVIR) FOR THE TREATMENT OF HIV-1 STRAINS RESISTENT INFECTIONS

28/10/2007 DORIBAX(R) (DORIPENEM), A NOVEL PENEM ANTIBACTERIAL

18/10/2007 AGREEMENT BETWEEN GLAXOSMITHKLINE AND SYNTA PHARMA FOR A NOVEL ANTIMELANOMA DRUG STA-4783

18/10/2007 NEW FDA ORPHAN DRUG MB07133 FOR THE TREATMENT OF LIVER CANCER

11/10/2007 NEW FDA ORPHAN DRUG: IPI-504 FOR GASTROINTESTINAL STROMAL TUMORS

10/10/2007 THE NOBEL PRIZE IN CHEMISTRY 2007

10/10/2007 TANESPIMYCIN, THE FIRST HSP90 INHIBITOR TO ENTER A REGISTRATION PROGRAM.

9/10/2007 THE NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE 2007

6/10/2007 FDA APPROVES NEW DRUG TO TREAT RARE DISEASE, ACROMEGALY

1/10/2007 FDA FAST TRACKS ANTI-CANCER PROGEN’S PI-88

28/9/2007 RECORDATI COMPLETES THE SILODOSIN PHASE III CLINICAL TRIALS

21/9/2007 OSTEOPOROSIS DRUG SUCCEEDS IN 3 YEARS STUDY

17/9/2007 FDA APPROVES LILLY'S OSTEOPOROSIS DRUG EVISTA(TM)

17/9/2007 POSITIVE REPORTS FROM PHASE II CLINICAL TRIALS ON ANTIFLAMMATORY TPI-1020

17/9/2007 LOOK AT JUICE

14/9/2007 ISENTRESS : A NOVEL ANTI-HIV APPROVED BY THE FDA

14/9/2007 PIXANTRONE, A NOVEL ANTHRACYCLINE

13/9/2007 EARLY DIAGNOSIS OF METASTASIS

5/9/2007 ELI LILLY OPENS DOOR FOR NEXT-GENERATION ANTIPSYCHOTICS

3/9/2007 CLOBUTINOL: AFTER 46 YEARS BANNED THE USE OF COUGH MEDICINES BECAUSE OF A POTENTIAL RISK OF IRREGULAR HEART BEAT

2/9/2007 BIOLOGICAL SCIENCES ON LINE

31/8/2007 TOTAL SYNTHESIS OF AZADIRACHTIN ACHIEVED

27/8/2007 THE FUTURE OF THE NOVEL DRUG FOR THE TREATMENT OF MALIGNANT MESOTELIOMA

21/8/2007 SANCTURA®, A MUSCARINIC RECEPTOR ANTAGONISTS FOR THE OVERACTIVE BLADDER

20/8/2007 PIVOTAL PHASE II CLINICAL TRIAL WITH TAMIBAROTENE IN REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA

19/8/2007 PI-88 FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

18/8/2007 FDA APPROVES SELZENTRY™ FOR THE TREATMENT OF HIV

2/8/2007 ABIRATERONE SHOWS PROMISE IN HORMONE-REFRACTIVE PROSTATE CANCER

2/8/2007 SPECTRUM PHARMACEUTICALS ACQUIRES FROM INDENA WORLDWIDE RIGHTS TO ORTATAXEL

2/8/2007 INITIATES PHASE I CLINICAL TRIAL A NOVEL HSP27 INHIBITOR

31/7/2007 TARGACEPT INC. INITIATES PHASE I CLINICAL TRIAL OF TC-5619

30/7/2007 GENAERA CORP. PRESENTS NEW PRECLINICAL DATA FOR OBESITY COMPOUND TRODUSQUEMINE (MSI-1436) AT CBI CONFERENCE

30/7/2007 NEW TARGET FOR HIV/AIDS DRUGS AND VACCINE DISCOVERED

24/7/2007 FDA APPROVES SCHWARZ PHARMA'S NEUPRO(R) - ROTIGONINE TRANSDERMAL SYSTEM - FOR THE TREATMENT OF EARLY-STAGE PARKINSON’S DISEASE IN USA.

23/7/2007 IMI: EVERYTHING READY IN ORDER TO START AT BEGINNING 2008

22/7/2007 EUROPEAN TRADITIONAL MEDICINES - INTERNAZIONAL CONGRESS

13/7/2007 A SYNERGIC EFFECT OF A TLR9 AGONIST AND BEVACIZUMAB IN TUMOR RESISTANT TO ANTI-EGFR DRUGS

13/7/2007 SUCCESS OF THE STRATEGIC US-ITALIAN COOPERATION TO FIGHT OVARIAN CANCER

10/7/2007 EFSA AND FDA STRENGTHEN COOPERATION IN FOOD SAFETY SCIENCE

8/7/2007 A NEW MOLECULE FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

8/7/2007 FDA APPROVES ALISKIREN: FIRST NEW ANTIHYPERTENSIVE ON THE MARKET IN MORE THAN 10 YEARS

8/7/2007 PFIZER’S LYRICA RECEIVES FDA APPROVAL FOR FIBROMYALGIA

8/7/2007 EXENATIDE: A NEW TYPE OF DRUG FOR TYPE 2 DIABETES NOW IN ITALY

3/7/2007 MEDITERRANEAN DIET ENRICHED WITH WALNUTS ALSO PROTECTS AGAINST OXIDATIVE DAMAGE

28/6/2007 ADDING FOLIC ACID TO BREAD COULD HELP IN THE FIGHT OF DEPRESSION

26/6/2007 NIKEM RESEARCH SRL ENTERS INTO RESEARCH SERVICE AGREEMENT WITH INTERMUNE INC.

21/6/2007 FDA APPROVES COMMERCIALIZATION OF DIFFERIN ® (ADAPALENE) GEL 0.3% FOR ACNE

21/6/2007 ITALIAN EURAND’S ZENTASE™ EFFECTIVE IN TREATING EXOCRINE PANCREATIC INSUFFICIENCY, STUDIES SHOW